CN101043878A - 用作片剂的脂肪胺聚合物盐 - Google Patents
用作片剂的脂肪胺聚合物盐 Download PDFInfo
- Publication number
- CN101043878A CN101043878A CNA2005800361808A CN200580036180A CN101043878A CN 101043878 A CN101043878 A CN 101043878A CN A2005800361808 A CNA2005800361808 A CN A2005800361808A CN 200580036180 A CN200580036180 A CN 200580036180A CN 101043878 A CN101043878 A CN 101043878A
- Authority
- CN
- China
- Prior art keywords
- monovalent anion
- carbonate
- tablet
- sevelamer
- aliphatic amine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2009—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/74—Synthetic polymeric materials
- A61K31/785—Polymers containing nitrogen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
- A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
- A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/18—Drugs for disorders of the endocrine system of the parathyroid hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Inorganic Chemistry (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Obesity (AREA)
- Endocrinology (AREA)
- Rheumatology (AREA)
- Urology & Nephrology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
Abstract
Description
方法 | %LOD | %Ceolus | %CSD | 使用的润滑剂 | %润滑剂 | 司维拉姆盐酸盐,lot# | 司维拉姆碳酸盐,lot# | Sev.HCl∶Sev.CO3wt.比率 | 硬度 | 60℃下储存的片剂核心崩解时间(分钟)。在pH值为1.2,带有碟和筛网的条件下进行 | |||
平均t=0 | 平均1周 | 平均2周 | 平均3周 | ||||||||||
只有司维拉姆碳酸盐物理混合的物理混合的 | 10.5888 | 14000 | 0.250.3750.3750.375 | 二山嵛酸甘油酯硬脂酸硬脂酸硬脂酸 | 1.20.40.40.4 | NA244826024482602448260 | 2416344241634424163442416344 | NA1到31到61到9 | 4313863279890 | 3.22.5ND1.72.3 | 32.42.7NDNDND | 34.82.4ND0.7ND | 36.82.4ND1.42.2 |
Sev.HCl∶Sev.CO3wt.比率 | PC(kN) | CF-(kN) | 成形性(N/kN) | 60℃下储存的片剂核心崩解时间(分钟)。在pH值为1.2,带有碟和筛网的条件下进行 | |||
平均t=0 | 平均t=0 | 平均t=0 | 平均t=0 | ||||
1到11到31到61到9 | 15151515 | 19444545 | 15.98.72.22.0 | 0.82.51.72.3 | 1.92.7NDND | 1.32.40.7ND | 1.32.41.42.2 |
方法 | %LOD | %Ceolus | 使用的润滑剂 | %润滑剂 | 司维拉姆盐酸盐,lot# | 司维拉姆碳酸盐,lot# | %氯化物 | 硬度 | 60℃下储存的片剂核心崩解时间(分钟)。在pH值为1.2,带有碟和筛网的条件下进行 | |||
平均t=0 | 平均1周 | 平均2周 | 平均3周 | |||||||||
物理混合化学混合物理混合化学混合 | 10.510.510.510.5 | 5555 | PRUVPRUV硬脂酸锌硬脂酸锌 | 0.50.50.50.5 | 2448260NA2448260NA | 2416344NA2416344NA | 4545 | 488305488116 | 1.112.11.07.1 | 2.411.34.46.7 | 2.811.24.96 | 3.311.55.26.2 |
方法 | %LOD | %Ceolus | 使用的润滑剂 | 司维拉姆碳酸盐,lot# | 硬度 | 60℃下储存的片剂核心崩解时间(分钟)。在pH值为1.2,带有碟和筛网的条件下进行 | |||
平均t=0 | 平均1周 | 平均2周 | 平均3周 | ||||||
无氯化钠0.25%氯化钠 | 10.510.5 | 1415 | 硬脂富马酸钠硬脂富马酸钠 | 24165702416344 | 194352 | 2.73.9 | 24.28.8 | ND9.4 | 29.513.4 |
试验记录编号 | 切割颗粒尺寸(微米) | 推顶力(N) | 紧密性(N/kN) | 60℃下储存的片剂核心崩解时间(分钟)。在pH值为1.2,带有碟和筛网的条件下进行 | |||
0495-2000484-1700484-1710484-1720484-138 | API原样>53>75>90>106 | 316326316320330 | 8.28.26.96.35.8 | 2.61.91.81.51.0 | 12.6NDNDND4.4 | 15.06.35.54.95.2 | 15.07.26.25.54.5 |
Claims (48)
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US62400104P | 2004-11-01 | 2004-11-01 | |
US60/624,001 | 2004-11-01 | ||
US62875204P | 2004-11-17 | 2004-11-17 | |
US60/628,752 | 2004-11-17 | ||
PCT/US2005/039366 WO2006050315A2 (en) | 2004-11-01 | 2005-11-01 | Aliphatic amine polymer salts for tableting |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201210341376XA Division CN102824322A (zh) | 2004-11-01 | 2005-11-01 | 用作片剂的脂肪胺聚合物盐 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN101043878A true CN101043878A (zh) | 2007-09-26 |
CN101043878B CN101043878B (zh) | 2012-11-14 |
Family
ID=36120243
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201210341376XA Pending CN102824322A (zh) | 2004-11-01 | 2005-11-01 | 用作片剂的脂肪胺聚合物盐 |
CN2005800361808A Active CN101043878B (zh) | 2004-11-01 | 2005-11-01 | 用作片剂的脂肪胺聚合物盐 |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201210341376XA Pending CN102824322A (zh) | 2004-11-01 | 2005-11-01 | 用作片剂的脂肪胺聚合物盐 |
Country Status (18)
Country | Link |
---|---|
US (4) | US7985418B2 (zh) |
EP (2) | EP3167878B1 (zh) |
JP (2) | JP5307398B2 (zh) |
CN (2) | CN102824322A (zh) |
AU (1) | AU2005302243B2 (zh) |
BR (1) | BRPI0517916B8 (zh) |
CA (2) | CA2762076C (zh) |
CY (1) | CY1119155T1 (zh) |
DK (1) | DK1807057T3 (zh) |
ES (2) | ES2716982T3 (zh) |
HK (1) | HK1113543A1 (zh) |
HR (1) | HRP20170505T1 (zh) |
HU (1) | HUE033638T2 (zh) |
LT (1) | LT1807057T (zh) |
MX (1) | MX2007004939A (zh) |
PL (1) | PL1807057T3 (zh) |
PT (1) | PT1807057T (zh) |
WO (1) | WO2006050315A2 (zh) |
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102641251A (zh) * | 2012-04-19 | 2012-08-22 | 天津太平洋制药有限公司 | 一种碳酸司维拉姆的可以在水中分散的片剂 |
CN102895204A (zh) * | 2012-11-08 | 2013-01-30 | 南京生命能科技开发有限公司 | 一种用于制备片剂的碳酸司维拉姆原料药及其制备方法和应用 |
CN105017481A (zh) * | 2010-02-24 | 2015-11-04 | 瑞立普萨公司 | 用作胆汁酸螯合剂的交联聚乙烯胺、聚烯丙胺和乙烯亚胺 |
CN107397734A (zh) * | 2017-08-24 | 2017-11-28 | 青岛正大海尔制药有限公司 | 一种稳定的碳酸司维拉姆片剂及其制备方法 |
WO2017215608A1 (en) * | 2016-06-14 | 2017-12-21 | Teligene Ltd | Sevelamer carbonate for tableting |
WO2023023939A1 (en) * | 2021-08-24 | 2023-03-02 | Waterstone Pharmaceuticals (Wuhan) Co., Ltd. | Polymers, compositions and methods for treating hyperuricemia |
WO2023023938A1 (en) * | 2021-08-24 | 2023-03-02 | Waterstone Pharmaceuticals (Wuhan) Co., Ltd. | Polymers, compositions and methods for treating hyperuricemia |
Families Citing this family (29)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6733780B1 (en) | 1999-10-19 | 2004-05-11 | Genzyme Corporation | Direct compression polymer tablet core |
US7985418B2 (en) | 2004-11-01 | 2011-07-26 | Genzyme Corporation | Aliphatic amine polymer salts for tableting |
EP1830832A1 (en) * | 2004-12-30 | 2007-09-12 | Genzyme Corporation | Zinc-containing treatments for hyperphosphatemia |
JP2009507019A (ja) | 2005-09-02 | 2009-02-19 | ジェンザイム・コーポレーション | リン酸塩を除去する方法およびそれに使用される重合体 |
KR101574072B1 (ko) | 2005-09-15 | 2015-12-04 | 젠자임 코포레이션 | 아민 중합체에 대한 샤셋 제형 |
CA2626734A1 (en) * | 2005-11-08 | 2007-05-18 | Genzyme Corporation | Magnesium-containing polymers for the treatment of hyperphosphatemia |
WO2008005217A2 (en) * | 2006-07-05 | 2008-01-10 | Genzyme Corporation | Iron(ii)-containing treatments for hyperphosphatemia |
US7964182B2 (en) * | 2006-09-01 | 2011-06-21 | USV, Ltd | Pharmaceutical compositions comprising phosphate-binding polymer |
EP2066293A2 (en) | 2006-09-29 | 2009-06-10 | Genzyme Corporation | Amide dendrimer compositions |
WO2008076242A1 (en) | 2006-12-14 | 2008-06-26 | Genzyme Corporation | Amido-amine polymer compositions |
EP2016947A1 (en) | 2007-07-17 | 2009-01-21 | Chemo Ibérica, S.A. | Novel one step process for preparing cross-linked poly(allylamine) polymers |
WO2009078958A1 (en) * | 2007-12-14 | 2009-06-25 | Genzyme Corporation | Coated pharmaceutical compositions |
CA2720865A1 (en) * | 2008-04-08 | 2009-10-15 | Usv Limited | Process for preparation of amine polymer salt |
DE102008030046A1 (de) | 2008-06-25 | 2009-12-31 | Ratiopharm Gmbh | Kompaktiertes Polyallylamin-Polymer |
WO2010041274A2 (en) * | 2008-10-07 | 2010-04-15 | Shasun Chemicals And Drugs Limited | Process for the preparation of carbonate salts of cross-linked amine polymers |
US8404784B2 (en) * | 2008-12-03 | 2013-03-26 | Navinta Llc | Manufacturing process of making polymeric amine salts |
US20100166861A1 (en) * | 2008-12-29 | 2010-07-01 | Kelly Noel Lynch | Pharmaceutical formulations of sevalamer, or salts thereof, and copovidone |
AU2010209293A1 (en) | 2009-01-22 | 2011-09-08 | Usv Limited | Pharmaceutical compositions comprising phosphate-binding polymer |
US20100330175A1 (en) * | 2009-06-24 | 2010-12-30 | Jobdevairakkam Christopher N | Cross-linked polyallylamine tablet core |
EP2545907A1 (en) | 2011-07-15 | 2013-01-16 | Combino Pharm, S.L. | Aqueous wet granulation process for cross-linked polyallylamine polymers |
LT3003327T (lt) | 2013-06-05 | 2017-12-27 | Tricida Inc. | Protonus surišantys polimerai, skirti geriamajam vartojimui |
CN103393610B (zh) * | 2013-07-05 | 2014-12-24 | 常州方圆制药有限公司 | 一种脂肪胺聚合物盐快速崩解制剂 |
MX2017007497A (es) | 2014-12-10 | 2017-10-04 | Tricida Inc | Polimeros de union a protones para administracion oral. |
RU2018142943A (ru) | 2016-05-06 | 2020-06-08 | Трисида, Инк. | Композиции для лечения нарушений кислотно-основного равновесия |
CN107157947A (zh) * | 2017-05-04 | 2017-09-15 | 方达医药技术(苏州)有限公司 | 一种碳酸司维拉姆片及其制备方法 |
US11266684B2 (en) | 2017-11-03 | 2022-03-08 | Tricida, Inc. | Compositions for and method of treating acid-base disorders |
WO2020138921A1 (ko) * | 2018-12-24 | 2020-07-02 | 동인당제약 주식회사 | 세벨라머 함유 경구투여용 현탁제 조성물 및 그 제조방법 |
KR102281492B1 (ko) | 2018-12-24 | 2021-07-26 | 동인당제약 주식회사 | 세벨라머 함유 경구투여용 현탁제 조성물 및 그 제조방법 |
CN113244339B (zh) * | 2021-06-04 | 2021-09-24 | 南京厚生药业有限公司 | 一种用于高脂血症的考来烯胺散及其制备方法 |
Family Cites Families (214)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2426125A (en) | 1944-04-03 | 1947-08-19 | Kelco Co | Manufacture of glycol alginates |
US2456428A (en) * | 1944-10-11 | 1948-12-14 | Shell Dev | Polyallyl amine and related polymeric amines |
US2463824A (en) | 1947-08-02 | 1949-03-08 | Kelco Co | Substituted alkylene glycol esters of alginic acid |
BE580490A (fr) | 1958-07-15 | 1960-01-08 | Merck & Co Inc | Compositions et procédés pour abaisser la teneur en cholestérol du sang |
US3104205A (en) * | 1959-12-17 | 1963-09-17 | Warner Lambert Pharmaceutical | Deodorant composition comprising the copper complex of the copolymer of allylamine and methacrylic acid |
US3308020A (en) * | 1961-09-22 | 1967-03-07 | Merck & Co Inc | Compositions and method for binding bile acids in vivo including hypocholesteremics |
US3332841A (en) * | 1961-10-04 | 1967-07-25 | Lilly Co Eli | Method of treating hyperacidity |
US3383236A (en) * | 1964-04-17 | 1968-05-14 | Merck & Co Inc | Continuous pharmaceutical film coating process |
US3624209A (en) * | 1966-12-28 | 1971-11-30 | Bristol Myers Co | Composition for treatment of gastro-intestinal disorders |
US3431138A (en) * | 1967-07-14 | 1969-03-04 | American Cyanamid Co | Method for coating pharmaceutical forms with methyl cellulose |
US3539380A (en) * | 1968-01-08 | 1970-11-10 | Upjohn Co | Methylcellulose and polyalkylene glycol coating of solid medicinal dosage forms |
DE1927336A1 (de) | 1968-06-17 | 1969-12-18 | Upjohn Co | Orale Dosierungsform zur Bekaempfung von Hypercholesterinaemie |
US3980770A (en) * | 1971-06-04 | 1976-09-14 | Pharmacia Aktiebolag | Polymerization products containing amino groups useful in serum cholesterol level control |
JPS5034095Y2 (zh) | 1971-10-09 | 1975-10-04 | ||
CH604722A5 (zh) | 1973-02-09 | 1978-09-15 | Sandoz Ag | |
AR206115A1 (es) | 1973-06-11 | 1976-06-30 | Merck & Co Inc | Procedimiento para preparar un polimero lineal no ramificado y no reticulado |
US4205064A (en) * | 1973-06-11 | 1980-05-27 | Merck & Co., Inc. | Bile acid sequestering composition containing poly[{alkyl-(3-ammoniopropyl)imino}-trimethylenedihalides] |
US4016209A (en) | 1975-04-23 | 1977-04-05 | Merck & Co., Inc. | 3-[N'-(3-Halopropyl)-N-'-methylamino]-N,N,N-trimethyl-1-propanaminium halide and acid addition salts thereof |
US4181718A (en) * | 1975-12-29 | 1980-01-01 | Mason Norbert S | Polyanion-stabilized aluminum hydrogels |
US4071478A (en) * | 1976-06-07 | 1978-01-31 | Merck & Co., Inc. | Controlled partially cross-linked 3,3-ionenes |
US4115537A (en) * | 1976-09-07 | 1978-09-19 | American Hospital Supply Corporation | Resin tablet and use thereof in diagnostic tests |
US4183918A (en) * | 1977-03-08 | 1980-01-15 | Exxon Research & Engineering Co. | Detoxifying-medicinal emulsions |
GB1566609A (en) | 1977-03-10 | 1980-05-08 | Reckitt & Colmann Prod Ltd | Pharmaceutical compositions containing cholestyramine and alginic acid |
GB1573487A (en) | 1977-05-23 | 1980-08-28 | Bristol Myers Co | Bile acid binding composition |
US4211763A (en) * | 1977-08-08 | 1980-07-08 | The Dow Chemical Company | Anion exchange resin in the determination of thyroid function |
US4143130A (en) * | 1977-08-29 | 1979-03-06 | Warren-Teed Laboratories, Inc. | Method for treating kidney stones |
JPS5566513A (en) | 1978-11-14 | 1980-05-20 | Ono Pharmaceut Co Ltd | Drug for arteriosclerosis comprising high polymer compound as active constituent |
US4341563A (en) * | 1978-11-17 | 1982-07-27 | Sankyo Company Limited | Protective coating compositions |
US4247393A (en) * | 1979-01-11 | 1981-01-27 | Wallace Richard A | Hemodialysis assist device |
US4264573A (en) * | 1979-05-21 | 1981-04-28 | Rowell Laboratories, Inc. | Pharmaceutical formulation for slow release via controlled surface erosion |
US4543370A (en) * | 1979-11-29 | 1985-09-24 | Colorcon, Inc. | Dry edible film coating composition, method and coating form |
US4439419A (en) | 1980-02-20 | 1984-03-27 | The Upjohn Company | Method of treating gastric hyperacidity in humans employing a copolymer of polyethylenepolyamine and a bifunctional substance as epichlorhydrin |
US4302440B1 (en) * | 1980-07-31 | 1986-08-05 | Easily-swallowed, powder-free and gastric-disintegrable aspirin tablet thinly-coated with hydroxypropyl methylcellulose and aqueous spray-coating preparation thereof | |
US4344993A (en) * | 1980-09-02 | 1982-08-17 | The Dow Chemical Company | Perfluorocarbon-polymeric coatings having low critical surface tensions |
DE3169753D1 (en) | 1980-12-12 | 1985-05-09 | Smith & Nephew Ass | Polymers, preparation and use |
JPS5879022A (ja) | 1981-11-04 | 1983-05-12 | Bitamin Kenkyusho:Kk | 第四級窒素原子を含有する新規な金属架橋高分子化合物、その製法及び該高分子化合物を有効成分とする高脂血症治療剤 |
JPS5879022U (ja) | 1981-11-26 | 1983-05-28 | 日産ディーゼル工業株式会社 | デイ−ゼル機関の吸気加熱装置 |
US4504640A (en) * | 1982-05-19 | 1985-03-12 | Nitto Boseki Co., Ltd. | Process for producing monoallylamine polymer |
EP0211991B1 (en) | 1982-07-08 | 1989-10-25 | Ab Leo | Substained release tablets and method for preparation thereof |
US4518433A (en) | 1982-11-08 | 1985-05-21 | Fmc Corporation | Enteric coating for pharmaceutical dosage forms |
US4507466A (en) | 1983-01-07 | 1985-03-26 | The Dow Chemical Corporation | Dense star polymers having core, core branches, terminal groups |
US4539198A (en) * | 1983-07-07 | 1985-09-03 | Rowell Laboratories, Inc. | Solid pharmaceutical formulations for slow, zero order release via controlled surface erosion: expanded range |
JPS6090243A (ja) * | 1983-10-25 | 1985-05-21 | Nitto Boseki Co Ltd | 小球状モノアリルアミン橋かけ重合体の製造方法 |
JPS60152424A (ja) | 1984-01-18 | 1985-08-10 | Daicel Chem Ind Ltd | 固形製剤 |
DE3572985D1 (en) | 1984-05-11 | 1989-10-19 | Bristol Myers Co | Novel bile sequestrant resin and uses |
US4688988A (en) | 1984-12-17 | 1987-08-25 | United Technologies Corporation | Coolable stator assembly for a gas turbine engine |
US4631305A (en) | 1985-03-22 | 1986-12-23 | The Upjohn Company | Polymeric material as a disintegrant in a compressed tablet |
DE3541511A1 (de) * | 1985-11-19 | 1987-05-21 | Grace W R Ab | Promoter fuer die papierleimung, verfahren zu dessen herstellung und dessen verwendung |
JPS62132830A (ja) | 1985-12-05 | 1987-06-16 | Teijin Ltd | 徐放性医薬品組成物 |
US4871779A (en) | 1985-12-23 | 1989-10-03 | The Dow Chemical Company | Ion exchange/chelation resins containing dense star polymers having ion exchange or chelate capabilities |
CH656535A5 (en) | 1986-01-24 | 1986-07-15 | Spirig Ag | Process for the production of stable pharmaceutical tablets which disintegrate rapidly in water |
JPS62132830U (zh) | 1986-02-18 | 1987-08-21 | ||
US4849227A (en) * | 1986-03-21 | 1989-07-18 | Eurasiam Laboratories, Inc. | Pharmaceutical compositions |
US5310572A (en) * | 1987-02-03 | 1994-05-10 | Dow Corning Corporation | Process for forming a coated active agent-containing article |
US4762524A (en) | 1987-02-05 | 1988-08-09 | Hoechst Celanese Corporation | Composition comprising the addition product of a vinyl-sulfone dye and a secondary amine and process for dyeing a polyamide therewith |
US5073380A (en) | 1987-07-27 | 1991-12-17 | Mcneil-Ppc, Inc. | Oral sustained release pharmaceutical formulation and process |
US4983398A (en) * | 1987-12-21 | 1991-01-08 | Forest Laboratories, Inc. | Sustained release drug dosage forms containing hydroxypropylmethylcellulose and alkali metal carboxylates |
US4853437A (en) | 1988-03-04 | 1989-08-01 | Hercules Incorporated | Water- and caustic-insoluble, inswellable, fibrous, particulate crosslinked polymer |
US5520932A (en) * | 1988-06-24 | 1996-05-28 | The Upjohn Company | Fine-milled colestipol hydrochloride |
US5807582A (en) * | 1988-08-26 | 1998-09-15 | Pharmacia & Upjohn Company | Fine-beaded colestipol hydrochloride and pharmaceutically elegant dosage forms made therefrom |
EP0429541B1 (en) | 1988-08-26 | 1993-12-01 | The Upjohn Company | Fine-beaded colestipol hydrochloride |
US5194464A (en) * | 1988-09-27 | 1993-03-16 | Takeda Chemical Industries, Ltd. | Enteric film and preparatoin thereof |
GB8829835D0 (en) | 1988-12-21 | 1989-02-15 | Smith Kline French Lab | Compounds |
DE3901527A1 (de) | 1989-01-20 | 1990-07-26 | Hoechst Ag | Alkylierte polyethyleniminderivate, verfahren zu ihrer herstellung, ihre verwendung als arzneimittel sowie pharmazeutische praeparate |
US4956182A (en) * | 1989-03-16 | 1990-09-11 | Bristol-Myers Company | Direct compression cholestyramine tablet and solvent-free coating therefor |
US5372823A (en) | 1989-03-16 | 1994-12-13 | Bristol-Myers Squibb Company | Direct compression cholestyramine tablet and solvent-free coating thereof |
US6274713B1 (en) * | 1989-04-07 | 2001-08-14 | Salutar, Inc. | Polychelants |
US5236701A (en) | 1989-07-19 | 1993-08-17 | Lowchol Scientific Inc. | Ingestible hydrophilic polymeric amines useful for lowering blood cholesterol |
JPH04503962A (ja) | 1989-08-07 | 1992-07-16 | ジ・アップジョン・カンパニー | 微細ビーズ化コレスチポール塩酸塩 |
US4983399A (en) * | 1989-10-18 | 1991-01-08 | Eastman Kodak Company | Direct compression carrier composition |
US5053423A (en) * | 1990-03-22 | 1991-10-01 | Quadra Logic Technologies Inc. | Compositions for photodynamic therapy |
JPH0687974B2 (ja) | 1990-03-27 | 1994-11-09 | 忠一 平山 | 発熱物質の吸着材料 |
DE4010271A1 (de) | 1990-03-30 | 1991-10-02 | Basf Ag | Verfahren zur herstellung von ethylenpolymerisaten bei druecken oberhalb von 500 bar in einem rohrreaktor mit einspritzfinger |
IE914179A1 (en) * | 1990-12-07 | 1992-06-17 | Ici Plc | Nitrogen derivatives |
US5262167A (en) * | 1990-12-20 | 1993-11-16 | Basf Corporation | Edible, non-baked low moisture cholestyramine composition |
RU1808015C (ru) | 1990-12-27 | 1993-04-07 | Владимир Андреевич Шевченко | Способ защиты млекопитающих от воздействи гамма-излучени |
US5055197A (en) * | 1991-04-05 | 1991-10-08 | Rohm And Haas Company | Process for removing residual monomers and oligemers from amine-containing polymers |
US5108767A (en) * | 1991-06-10 | 1992-04-28 | Abbott Laboratories | Liquid nutritional product for persons receiving renal dialysis |
ES2124736T3 (es) | 1991-07-03 | 1999-02-16 | Upjohn Co | Comprimidos con alto contenido de clorhidrato de colestipol. |
US5840339A (en) * | 1991-07-30 | 1998-11-24 | Kunin; Robert | Blood cholesterol reducing pharmaceutical composition |
JP2785529B2 (ja) | 1991-08-21 | 1998-08-13 | 日東紡績株式会社 | エタノール徐放剤およびそれを用いた食品保存用組成物 |
EP0534304A1 (de) | 1991-09-21 | 1993-03-31 | Hoechst Aktiengesellschaft | Cycloalkylierte Polyethyleniminderivate und ihre Verwendung als Hypolipidämika |
SE470006B (sv) | 1991-09-26 | 1993-10-25 | Corline Systems Ab | Nytt konjugat, dess framställning och användning samt substrat preparerat med konjugatet |
JPH05170845A (ja) | 1991-12-20 | 1993-07-09 | Nippon Paint Co Ltd | 有機ポリマー微粒子およびその製法 |
US5610268A (en) | 1992-01-13 | 1997-03-11 | Dsm N.V. | Dendritic macromolecule and the preparation thereof |
US5530092A (en) | 1992-01-13 | 1996-06-25 | Dsm N.V. | Dendritic macromolecule and the preparation thereof |
US5654003A (en) * | 1992-03-05 | 1997-08-05 | Fuisz Technologies Ltd. | Process and apparatus for making tablets and tablets made therefrom |
EP0580079B1 (de) * | 1992-07-22 | 1996-12-11 | Hoechst Aktiengesellschaft | Vernetzte, stickstoffhaltige Vinylcopolymere, Verfahren zu ihrer Herstellung sowie die Verwendung dieser Verbindungen |
EP0580078B1 (de) * | 1992-07-22 | 1997-10-15 | Hoechst Aktiengesellschaft | Hydrophile Zentren aufweisende Polyvinylamin-Derivate, Verfahren zu ihrer Herstellung sowie die Verwendung der Verbindungen als Arzneimittel, Wirkstoffträger und Nahrungsmittelhilfsstoff |
WO1994004596A1 (en) | 1992-08-20 | 1994-03-03 | E.I. Du Pont De Nemours And Company | Crosslinked polymeric ammonium salts |
US5302531A (en) * | 1992-10-22 | 1994-04-12 | Miles Inc. | Composition for the semiquantitative determination of specific gravity of a test sample |
EP0605757B1 (en) | 1992-11-25 | 2001-08-16 | Ajinomoto Co., Inc. | Compositions and goods containing minerals and poly-gamma-glutamic acid |
EP0684958B1 (en) | 1993-02-17 | 1998-06-10 | Btg International Limited | Polymers containing guanidino groups for use in therapy |
US5376396A (en) | 1993-04-27 | 1994-12-27 | Merck & Co., Inc. | Beverage stabilizing system and process thereof |
JPH06321786A (ja) | 1993-05-12 | 1994-11-22 | Sekisui Chem Co Ltd | 胆汁酸腸管吸収抑制剤 |
US5487888A (en) * | 1993-05-20 | 1996-01-30 | Geltex, Inc. | Iron-binding polymers for oral administration |
US5900475A (en) | 1994-06-10 | 1999-05-04 | Geltex Pharmaceuticals, Inc. | Hydrophobic sequestrant for cholesterol depletion |
WO1994027620A1 (en) | 1993-06-02 | 1994-12-08 | Geltex Pharmaceuticals, Inc. | Compositions and process for removing bile salts |
US5607669A (en) | 1994-06-10 | 1997-03-04 | Geltex Pharmaceuticals, Inc. | Amine polymer sequestrant and method of cholesterol depletion |
US5624963A (en) * | 1993-06-02 | 1997-04-29 | Geltex Pharmaceuticals, Inc. | Process for removing bile salts from a patient and compositions therefor |
US5618530A (en) * | 1994-06-10 | 1997-04-08 | Geltex Pharmaceuticals, Inc. | Hydrophobic amine polymer sequestrant and method of cholesterol depletion |
US5703188A (en) | 1993-06-02 | 1997-12-30 | Geltex Pharmaceuticals, Inc. | Process for removing bile salts from a patient and compositions therefor |
CA2129079C (en) * | 1993-08-03 | 2006-01-17 | Tatsuo Nomura | Orally administrable cholesterol lowering agent |
US5496545A (en) | 1993-08-11 | 1996-03-05 | Geltex Pharmaceuticals, Inc. | Phosphate-binding polymers for oral administration |
US5667775A (en) | 1993-08-11 | 1997-09-16 | Geltex Pharmaceuticals, Inc. | Phosphate-binding polymers for oral administration |
JPH09506342A (ja) * | 1993-11-25 | 1997-06-24 | サルテルナテ・ベー・ブイ | 一価カチオンに結合する粒子、並びにナトリウムおよび/またはカリウムイオンを捕捉して除去するための上記粒子の使用および方法 |
US5445047A (en) * | 1993-11-29 | 1995-08-29 | Chi; Yi C. | Hanger means for a wheeled vehicle |
US5414068A (en) * | 1994-01-24 | 1995-05-09 | Rohm And Haas Company | Crosslinked anion exchange particles and method for producing the particles |
TW474813B (en) | 1994-06-10 | 2002-02-01 | Geltex Pharma Inc | Alkylated composition for removing bile salts from a patient |
AUPM623994A0 (en) | 1994-06-15 | 1994-07-07 | Biomolecular Research Institute Limited | Antiviral dendrimers |
JP3355593B2 (ja) * | 1994-08-19 | 2002-12-09 | 信越化学工業株式会社 | 固形腸溶製剤の製造方法 |
WO1996021454A1 (en) | 1995-01-12 | 1996-07-18 | Geltex Pharmaceuticals, Inc. | Phosphate-binding polymers for oral administration |
GB9503061D0 (en) | 1995-02-16 | 1995-04-05 | British Tech Group | Polymeric compounds |
JP2936129B2 (ja) | 1995-04-12 | 1999-08-23 | セイコー精機株式会社 | 防食構造 |
US5686106A (en) * | 1995-05-17 | 1997-11-11 | The Procter & Gamble Company | Pharmaceutical dosage form for colonic delivery |
US5561214A (en) | 1995-05-18 | 1996-10-01 | Bayer Corporation | Hyperbranched polyaspartate esters and a process for their preparation |
US5709880A (en) * | 1995-07-10 | 1998-01-20 | Buckman Laboratories International, Inc. | Method of making tabletized ionene polymers |
TW438608B (en) | 1995-08-02 | 2001-06-07 | Hisamitsu Pharmaceutical Co | A tablet containing anion exchange resin |
GB2308363A (en) | 1995-12-22 | 1997-06-25 | Courtaulds Coatings | Dendritic Polymers |
FI104823B (fi) | 1996-06-24 | 2000-04-14 | Borealis Polymers Oy | Likaantumista estävä päällyste |
US6034129A (en) * | 1996-06-24 | 2000-03-07 | Geltex Pharmaceuticals, Inc. | Ionic polymers as anti-infective agents |
US5747067A (en) * | 1996-12-06 | 1998-05-05 | Fmc Corporation | Co-processed products |
DE19654179A1 (de) | 1996-12-23 | 1998-06-25 | Basf Ag | H-förmige Polyamide |
US6203785B1 (en) * | 1996-12-30 | 2001-03-20 | Geltex Pharmaceuticals, Inc. | Poly(diallylamine)-based bile acid sequestrants |
AU2446497A (en) | 1997-03-25 | 1998-10-20 | Geltex Pharmaceuticals, Inc. | Phosphate-binding polymers combined with a calcium supplement for oral administration |
TW592727B (en) | 1997-04-04 | 2004-06-21 | Chugai Pharmaceutical Co Ltd | Phosphate-binding polymer preparations |
JPH10316576A (ja) | 1997-05-13 | 1998-12-02 | Nissui Pharm Co Ltd | キトサン含有錠剤 |
US6423754B1 (en) | 1997-06-18 | 2002-07-23 | Geltex Pharmaceuticals, Inc. | Method for treating hypercholesterolemia with polyallylamine polymers |
DE69834255T2 (de) * | 1997-07-25 | 2006-09-28 | Alpex Pharma S.A. | Verfahren zur herstellung eines granulates, geeignet zur herstellung schnell-freisetzender, im mund löslicher tabletten |
US6187897B1 (en) | 1997-09-01 | 2001-02-13 | Toyo Ink Manufacturing Co., Ltd. | Vinyl-group-containing dendrimer and curable composition |
US6290947B1 (en) | 1997-09-19 | 2001-09-18 | Geltex Pharmaceuticals, Inc. | Ionic polymers as toxin-binding agents |
US6566407B2 (en) * | 1997-11-05 | 2003-05-20 | Geltex Pharmaceuticals, Inc. | Method for reducing oxalate |
US5985938A (en) * | 1997-11-05 | 1999-11-16 | Geltex Pharmaceuticals, Inc. | Method for reducing oxalate |
US6726905B1 (en) | 1997-11-05 | 2004-04-27 | Genzyme Corporation | Poly (diallylamines)-based phosphate binders |
US6083497A (en) | 1997-11-05 | 2000-07-04 | Geltex Pharmaceuticals, Inc. | Method for treating hypercholesterolemia with unsubstituted polydiallylamine polymers |
US6264937B1 (en) * | 1998-01-09 | 2001-07-24 | Geltex Pharmaceuticals, Inc. | Fat-binding polymers |
US6090411A (en) * | 1998-03-09 | 2000-07-18 | Temple University | Monolithic tablet for controlled drug release |
DE19835467A1 (de) * | 1998-08-06 | 2000-02-17 | Elenac Gmbh | Feststoffreaktor mit antistatischer Beschichtung zur Durchführung von Reaktionen in der Gasphase |
US6099862A (en) * | 1998-08-31 | 2000-08-08 | Andrx Corporation | Oral dosage form for the controlled release of a biguanide and sulfonylurea |
TW568788B (en) | 1998-10-12 | 2004-01-01 | Chugai Pharmaceutical Co Ltd | Polymer combining with phosphoric acid and preparation containing the same |
JP2000178182A (ja) | 1998-12-17 | 2000-06-27 | Lion Corp | 崩壊性組成物 |
US6362266B1 (en) | 1999-09-03 | 2002-03-26 | The Dow Chemical Company | Process for reducing cohesiveness of polyallylamine polymer gels during drying |
US6180754B1 (en) * | 1999-09-03 | 2001-01-30 | The Dow Chemical Company | Process for producing cross-linked polyallylamine polymer |
CA2385749A1 (en) | 1999-09-28 | 2001-04-05 | H. Lundbeck A/S | Melt granulated composition and modified release dosage form prepared from said composition |
US20020054903A1 (en) * | 1999-10-19 | 2002-05-09 | Joseph Tyler | Direct compression polymer tablet core |
US6733780B1 (en) * | 1999-10-19 | 2004-05-11 | Genzyme Corporation | Direct compression polymer tablet core |
ATE286386T1 (de) * | 1999-10-19 | 2005-01-15 | Genzyme Corp | Direktkomprimierter tablettenkern auf polymerbasis |
WO2001066607A1 (fr) | 2000-03-09 | 2001-09-13 | Hisamitsu Pharmaceutical Co., Inc. | Resine echangeuse d'anions reticulee ou sel de celle-ci et adsorbant phosphoreux la contenant |
WO2001068106A1 (fr) | 2000-03-13 | 2001-09-20 | Hisamitsu Pharmaceutical Co., Inc. | Prophylactiques et/ou remedes pour hyperphosphatemie |
CN1290515A (zh) | 2000-10-19 | 2001-04-11 | 赵明 | 一种可调节性人工晶体 |
DE60132256T2 (de) | 2000-11-20 | 2008-12-24 | Sorbent Therapeutics, Inc., Vernon Hills | Wasserabsorbierende polymere und deren verwendung |
US20030175349A1 (en) * | 2001-01-30 | 2003-09-18 | Council Of Scientific And Industrial Research | Pharmaceutical compostion for extended/sustained release of a therapeutically active ingredient |
US6534600B2 (en) | 2001-03-26 | 2003-03-18 | Michigan Molecular Institute | Hyperbranched polyureas, polyurethanes, polyamidoamines, polyamides and polyesters |
WO2002085383A1 (en) | 2001-04-18 | 2002-10-31 | Genzyme Corporation | Method for reducing copper levels and treating copper toxicosis |
JP2004528332A (ja) | 2001-04-18 | 2004-09-16 | ジェンザイム コーポレーション | 痛風を治療する方法および尿酸を結合する方法 |
KR20040018357A (ko) * | 2001-04-18 | 2004-03-03 | 젠자임 코포레이션 | 저염 형태의 폴리알릴아민 |
BR0209124A (pt) * | 2001-04-18 | 2005-02-09 | Genzyme Corp | Método para tratar uma sìndrome x ou inibir o inìcio dos sintomas da sìndrome x e uso de uma quantidade terapeuticamente efetiva de um sal de pelo menos um polìmero de amina alifática |
AU2002257145B2 (en) | 2001-04-18 | 2005-06-02 | Genzyme Corporation | Method for lowering serum glucose |
WO2002085379A1 (en) | 2001-04-18 | 2002-10-31 | Geltex Pharmaceuticals, Inc. | Method for improving vascular access in patients with vascular shunts |
WO2002085380A1 (en) | 2001-04-18 | 2002-10-31 | Geltex Pharmaceuticals, Inc. | Method for treating gout and reducing serum uric acid |
WO2003002071A2 (en) | 2001-06-29 | 2003-01-09 | Lewandowski Leon J | Individualized addiction cessation therapy |
CN1270724C (zh) | 2001-07-30 | 2006-08-23 | 三菱制药株式会社 | 餐后高血糖改善剂 |
WO2003031501A1 (en) * | 2001-10-09 | 2003-04-17 | Genzyme Corporation | Process for purification and drying of polymer hydrogels |
US6600011B2 (en) | 2001-10-09 | 2003-07-29 | Genzyme Corporation | Process for purification and drying of polymer hydrogels |
US7815936B2 (en) | 2001-10-30 | 2010-10-19 | Evonik Degussa Gmbh | Use of granular materials based on pyrogenically produced silicon dioxide in pharmaceutical compositions |
DE10163163A1 (de) | 2001-12-20 | 2003-07-03 | Basf Ag | Verfahren zur Herstellung hochfunktioneller, Hyperverzweigter Polyester durch enzymatische Veresterung |
US7208314B2 (en) | 2002-02-26 | 2007-04-24 | Mirus Bio Corporation | Compositions and methods for drug delivery using pH sensitive molecules |
US20030161875A1 (en) * | 2002-02-27 | 2003-08-28 | Deepak Murpani | Fast dissolving tablets of cyclooxygenase-2 enzyme inhibitors |
US7109184B2 (en) * | 2002-03-19 | 2006-09-19 | Genzyme Corporation | Phosphate transport inhibitors |
US20030180250A1 (en) | 2002-03-22 | 2003-09-25 | Council Of Scientific And Industrial Research | Compositions and complexes containing a macromolecular compound as potential anti-inflammatory agents |
US7169450B2 (en) | 2002-05-15 | 2007-01-30 | Mcneil-Ppc, Inc. | Enrobed core |
US20040161474A1 (en) | 2002-05-24 | 2004-08-19 | Moerck Rudi E. | Rare earth metal compounds methods of making, and methods of using the same |
ITMI20021718A1 (it) | 2002-07-31 | 2004-02-01 | Sematic Italia Spa | Interruttore di sicurezza con sistema elettronico programmabile. |
GB0218781D0 (en) * | 2002-08-13 | 2002-09-18 | Astrazeneca Ab | Chemical process |
DE10243545B4 (de) | 2002-09-19 | 2008-05-21 | Osram Opto Semiconductors Gmbh | Optisch gepumpte Halbleiterlaservorrichtung |
AU2003282867A1 (en) | 2002-10-22 | 2004-05-13 | Genzyme Corporation | Amine polymers for promoting bone formation |
DE10250711A1 (de) | 2002-10-31 | 2004-05-19 | Degussa Ag | Pharmazeutische und kosmetische Zubereitungen |
US9107804B2 (en) | 2002-12-10 | 2015-08-18 | Nortec Development Associates, Inc. | Method of preparing biologically active formulations |
WO2004099288A1 (en) | 2003-05-09 | 2004-11-18 | Carlsberg A/S | Polyethyleneimine polymers |
TW200507882A (en) * | 2003-07-17 | 2005-03-01 | Kyowa Hakko Kogyo Kk | Solid formulations |
WO2005021000A1 (en) * | 2003-08-28 | 2005-03-10 | Ranbaxy Laboratories Limited | Solid oral dosage forms of gatifloxacin |
US7385012B2 (en) * | 2003-11-03 | 2008-06-10 | Ilypsa, Inc. | Polyamine polymers |
US7608674B2 (en) | 2003-11-03 | 2009-10-27 | Ilypsa, Inc. | Pharmaceutical compositions comprising cross-linked small molecule amine polymers |
US7459502B2 (en) * | 2003-11-03 | 2008-12-02 | Ilypsa, Inc. | Pharmaceutical compositions comprising crosslinked polyamine polymers |
US7767768B2 (en) | 2003-11-03 | 2010-08-03 | Ilypsa, Inc. | Crosslinked amine polymers |
US7449605B2 (en) * | 2003-11-03 | 2008-11-11 | Ilypsa, Inc. | Crosslinked amine polymers |
US7335795B2 (en) | 2004-03-22 | 2008-02-26 | Ilypsa, Inc. | Crosslinked amine polymers |
US20050208095A1 (en) | 2003-11-20 | 2005-09-22 | Angiotech International Ag | Polymer compositions and methods for their use |
US7309500B2 (en) | 2003-12-04 | 2007-12-18 | The Board Of Trustees Of The University Of Illinois | Microparticles |
EP1699442A2 (en) | 2003-12-31 | 2006-09-13 | Genzyme Corporation | Enteric coated aliphatic amine polymer bile acid sequestrants |
US8192758B2 (en) | 2004-03-30 | 2012-06-05 | Relypsa, Inc. | Ion binding compositions |
US7556799B2 (en) | 2004-03-30 | 2009-07-07 | Relypsa, Inc. | Ion binding polymers and uses thereof |
US8282960B2 (en) | 2004-03-30 | 2012-10-09 | Relypsa, Inc. | Ion binding compositions |
US7429394B2 (en) | 2004-03-30 | 2008-09-30 | Relypsa, Inc. | Ion binding compositions |
KR20050104152A (ko) | 2004-04-28 | 2005-11-02 | 최승호 | 경구용 약물의 흡수를 증진하는 약제학적 조성물 |
DK2258349T3 (da) | 2004-05-11 | 2014-10-13 | Egalet Ltd | Kvældbar doseringsform omfattende gellangummi |
US7973122B2 (en) | 2004-06-17 | 2011-07-05 | General Cable Technologies Corporation | Polyamideimide compositions having multifunctional core structures |
US20060024368A1 (en) | 2004-07-30 | 2006-02-02 | Reza Fassihi | Compressed composite delivery system for release-rate modulation of bioactives |
US7218130B2 (en) | 2004-08-25 | 2007-05-15 | Micron Technology, Inc. | Bottom side stiffener probe card |
US7019085B2 (en) | 2004-08-30 | 2006-03-28 | Albright Robert L | Phosphate selective resin and related methods |
TWM271254U (en) * | 2004-09-10 | 2005-07-21 | Sen Tech Co Ltd | Heat dissipation base and package structure for light-emitting diode |
AU2005296290A1 (en) | 2004-10-13 | 2006-04-27 | Ilypsa, Inc. | Crosslinked amine polymers |
CA2583548A1 (en) | 2004-10-15 | 2006-04-27 | Altairnano, Inc. | Phosphate binder with reduced pill burden |
US20060177415A1 (en) | 2004-11-01 | 2006-08-10 | Burke Steven K | Once a day formulation for phosphate binders |
US7985418B2 (en) | 2004-11-01 | 2011-07-26 | Genzyme Corporation | Aliphatic amine polymer salts for tableting |
EP1830832A1 (en) | 2004-12-30 | 2007-09-12 | Genzyme Corporation | Zinc-containing treatments for hyperphosphatemia |
CA2601236A1 (en) | 2005-03-16 | 2006-09-21 | Usv Limited | An improved process for the preparation of crosslinked polyallylamine polymer |
DE102005037632A1 (de) | 2005-08-09 | 2007-02-15 | Hilti Ag | Wanddetektor |
CA2622021C (en) | 2005-09-14 | 2014-07-15 | Wisconsin Alumni Research Foundation | Composition comprising a dendrimer and the use thereof for binding phosphate |
KR101574072B1 (ko) | 2005-09-15 | 2015-12-04 | 젠자임 코포레이션 | 아민 중합체에 대한 샤셋 제형 |
US20070094779A1 (en) | 2005-10-31 | 2007-05-03 | Dauphin Joseph A | Three piece toilet maintenance kit |
US20070110707A1 (en) | 2005-11-04 | 2007-05-17 | Washington University | Method of treating diseases involving non-enzymatic glycation |
JP5034095B2 (ja) | 2007-07-13 | 2012-09-26 | 株式会社リコー | プリント配線基板および電子装置 |
WO2009064284A1 (en) | 2007-11-12 | 2009-05-22 | Gkn Driveline North America, Inc. | Drive shaft with array tuned absorber |
-
2005
- 2005-10-27 US US11/262,291 patent/US7985418B2/en active Active
- 2005-11-01 PT PT58148800T patent/PT1807057T/pt unknown
- 2005-11-01 DK DK05814880.0T patent/DK1807057T3/en active
- 2005-11-01 EP EP16199305.0A patent/EP3167878B1/en active Active
- 2005-11-01 WO PCT/US2005/039366 patent/WO2006050315A2/en active Application Filing
- 2005-11-01 CA CA 2762076 patent/CA2762076C/en not_active Expired - Fee Related
- 2005-11-01 AU AU2005302243A patent/AU2005302243B2/en active Active
- 2005-11-01 HU HUE05814880A patent/HUE033638T2/en unknown
- 2005-11-01 BR BRPI0517916A patent/BRPI0517916B8/pt not_active IP Right Cessation
- 2005-11-01 JP JP2007539273A patent/JP5307398B2/ja active Active
- 2005-11-01 CN CN201210341376XA patent/CN102824322A/zh active Pending
- 2005-11-01 ES ES16199305T patent/ES2716982T3/es active Active
- 2005-11-01 LT LTEP05814880.0T patent/LT1807057T/lt unknown
- 2005-11-01 EP EP05814880.0A patent/EP1807057B1/en active Active
- 2005-11-01 CN CN2005800361808A patent/CN101043878B/zh active Active
- 2005-11-01 CA CA2586023A patent/CA2586023C/en not_active Expired - Fee Related
- 2005-11-01 MX MX2007004939A patent/MX2007004939A/es active IP Right Grant
- 2005-11-01 ES ES05814880.0T patent/ES2621553T3/es active Active
- 2005-11-01 PL PL05814880T patent/PL1807057T3/pl unknown
-
2008
- 2008-03-25 HK HK08103313.6A patent/HK1113543A1/xx active IP Right Revival
-
2011
- 2011-07-14 US US13/183,079 patent/US8808738B2/en active Active
-
2013
- 2013-04-19 JP JP2013087963A patent/JP5758945B2/ja active Active
-
2014
- 2014-07-09 US US14/326,877 patent/US9555056B2/en active Active
-
2016
- 2016-12-14 US US15/378,320 patent/US9895315B2/en active Active
-
2017
- 2017-03-28 HR HRP20170505TT patent/HRP20170505T1/hr unknown
- 2017-04-10 CY CY20171100424T patent/CY1119155T1/el unknown
Cited By (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105017481A (zh) * | 2010-02-24 | 2015-11-04 | 瑞立普萨公司 | 用作胆汁酸螯合剂的交联聚乙烯胺、聚烯丙胺和乙烯亚胺 |
CN102641251A (zh) * | 2012-04-19 | 2012-08-22 | 天津太平洋制药有限公司 | 一种碳酸司维拉姆的可以在水中分散的片剂 |
CN102641251B (zh) * | 2012-04-19 | 2013-11-27 | 天津太平洋制药有限公司 | 一种碳酸司维拉姆的可以在水中分散的片剂 |
CN102895204A (zh) * | 2012-11-08 | 2013-01-30 | 南京生命能科技开发有限公司 | 一种用于制备片剂的碳酸司维拉姆原料药及其制备方法和应用 |
CN102895204B (zh) * | 2012-11-08 | 2014-12-31 | 南京生命能科技开发有限公司 | 一种用于制备片剂的碳酸司维拉姆原料药及其制备方法和应用 |
WO2017215608A1 (en) * | 2016-06-14 | 2017-12-21 | Teligene Ltd | Sevelamer carbonate for tableting |
CN109715142A (zh) * | 2016-06-14 | 2019-05-03 | 苏州韬略生物科技有限公司 | 用于压片的碳酸司维拉姆 |
CN109715142B (zh) * | 2016-06-14 | 2021-10-12 | 苏州韬略生物科技有限公司 | 用于压片的碳酸司维拉姆 |
CN107397734A (zh) * | 2017-08-24 | 2017-11-28 | 青岛正大海尔制药有限公司 | 一种稳定的碳酸司维拉姆片剂及其制备方法 |
CN107397734B (zh) * | 2017-08-24 | 2020-06-30 | 正大制药(青岛)有限公司 | 一种稳定的碳酸司维拉姆片剂及其制备方法 |
WO2023023939A1 (en) * | 2021-08-24 | 2023-03-02 | Waterstone Pharmaceuticals (Wuhan) Co., Ltd. | Polymers, compositions and methods for treating hyperuricemia |
WO2023023938A1 (en) * | 2021-08-24 | 2023-03-02 | Waterstone Pharmaceuticals (Wuhan) Co., Ltd. | Polymers, compositions and methods for treating hyperuricemia |
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101043878A (zh) | 用作片剂的脂肪胺聚合物盐 | |
CN101043895A (zh) | 一次日剂量磷酸盐粘结剂制剂 | |
CN1209091C (zh) | 硬胶囊 | |
CN1652760A (zh) | 坦洛新片剂 | |
CN1109328A (zh) | 24小时释放甲氧乙心安的持续释放制剂 | |
CN1089471A (zh) | 稳定的延长释放口服组合物 | |
CN1219879A (zh) | 药用组合物 | |
CN1913875A (zh) | 作为药物载体的具有pH依赖性调节释放性质的阴离子水凝胶基质 | |
CN1538837A (zh) | 含有对乙酰氨基酚的吞咽片 | |
CN1188113C (zh) | 含有profen和其它活性化合物的组合的药物混合物 | |
CN1133709A (zh) | 盐酸地尔硫䓬控释片的制备方法 | |
CN1272014C (zh) | 一种阿仑膦酸盐肠溶制剂及其制备方法 | |
AU2012200480B2 (en) | "Aliphatic amine polymer salts for tableting" | |
CN1640400A (zh) | 非洛地平控释制剂 | |
CN1543956A (zh) | 复方氨酚那敏缓释片和制备方法 | |
CN1449750A (zh) | 加巴喷丁缓释组合物 | |
CN1626108A (zh) | 阿卡波糖肠溶片及制备方法 | |
CN1568180A (zh) | 控制释放4-氨基-6,7-二甲氧基-2-(5-甲磺酰氨基-1,2,3,4-四氢异喹啉-2-基)-5-(2-吡啶基)喹唑啉的药物制剂 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
REG | Reference to a national code |
Ref country code: HK Ref legal event code: DE Ref document number: 1113543 Country of ref document: HK |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
REG | Reference to a national code |
Ref country code: HK Ref legal event code: GR Ref document number: 1113543 Country of ref document: HK |
|
EE01 | Entry into force of recordation of patent licensing contract | ||
EE01 | Entry into force of recordation of patent licensing contract |
Application publication date: 20070926 Assignee: Senofi (Hangzhou) Pharmaceutical Co.,Ltd. Assignor: GENZYME Corp. Contract record no.: X2022990000593 Denomination of invention: Fatty amine polymer salt for tablet use Granted publication date: 20121114 License type: Common License Record date: 20220905 |